152 related articles for article (PubMed ID: 25380351)
21. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.
Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G
J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409
[TBL] [Abstract][Full Text] [Related]
22. HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma.
Sun J; Sun B; Sun R; Zhu D; Zhao X; Zhang Y; Dong X; Che N; Li J; Liu F; Zhao N; Wang Y; Zhang D
Sci Rep; 2017 May; 7(1):2229. PubMed ID: 28533522
[TBL] [Abstract][Full Text] [Related]
23. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
[TBL] [Abstract][Full Text] [Related]
24. IMP-3 expression in melanocytic lesions.
Yu L; Xu H; Wasco MJ; Bourne PA; Ma L
J Cutan Pathol; 2010 Mar; 37(3):316-22. PubMed ID: 19788446
[TBL] [Abstract][Full Text] [Related]
25. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
26. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
27. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas.
Yan J; Zhang Y; Shi W; Ren C; Liu Y; Pan Y
Tumour Biol; 2016 Jan; 37(1):823-8. PubMed ID: 26250458
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6-induced Twist and N-cadherin enhance melanoma cell metastasis.
Na YR; Lee JS; Lee SJ; Seok SH
Melanoma Res; 2013 Dec; 23(6):434-43. PubMed ID: 24051540
[TBL] [Abstract][Full Text] [Related]
29. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.
Delaunay T; Deschamps L; Haddada M; Walker F; Soosaipillai A; Soualmia F; El Amri C; Diamandis EP; Brattsand M; Magdolen V; Darmoul D
Mol Oncol; 2017 Oct; 11(10):1330-1347. PubMed ID: 28636767
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA HEIH promotes melanoma cell proliferation, migration and invasion via inhibition of
Zhao H; Xing G; Wang Y; Luo Z; Liu G; Meng H
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28487474
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
[TBL] [Abstract][Full Text] [Related]
33. High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.
Liu Z; Wu K; Yang Z; Wu A
Mol Cell Biochem; 2015 Nov; 409(1-2):155-62. PubMed ID: 26183485
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.
Kato T; Hayama S; Yamabuki T; Ishikawa N; Miyamoto M; Ito T; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):434-42. PubMed ID: 17255263
[TBL] [Abstract][Full Text] [Related]
35. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
36. Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor.
Pocza P; Süli-Vargha H; Darvas Z; Falus A
Int J Cancer; 2008 May; 122(9):1972-80. PubMed ID: 18076073
[TBL] [Abstract][Full Text] [Related]
37. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
38. High mobility group AT-hook 2 promotes tumorigenicity of pancreatic cancer cells via upregulating ANLN.
Guo HH; Wang YZ; Zhang ZK; Li MZ; Tian XD; Yang YM
Exp Cell Res; 2020 Aug; 393(1):112088. PubMed ID: 32413362
[TBL] [Abstract][Full Text] [Related]
39. TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling.
Yin J; Kim TH; Park N; Shin D; Choi HI; Cho S; Park JB; Kim JH
Oncotarget; 2016 Nov; 7(48):79854-79868. PubMed ID: 27821801
[TBL] [Abstract][Full Text] [Related]
40. eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.
Khosravi S; Tam KJ; Ardekani GS; Martinka M; McElwee KJ; Ong CJ
J Invest Dermatol; 2015 May; 135(5):1358-1367. PubMed ID: 25562667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
